BillionToOne - Starting 2026 Strong
BillionToOne has reported an impressive 84% year-over-year sales growth in Q1, primarily due to its prenatal and oncology testing services. The company has also increased its revenue guidance for the full year to between $450 million and $465 million, indicating strong market demand. Additionally, BillionToOne achieved a GAAP operating profit of $17.8 million, showcasing its operational efficiency and margin improvement.
- ▪BillionToOne posted 84% year-over-year sales growth in Q1.
- ▪The company raised its full-year revenue guidance to $450–$465 million.
- ▪GAAP operating profit reached $17.8 million, reflecting operational leverage.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Stock Ideas","item":"https://seekingalpha.com/stock-ideas"},{"@type":"ListItem","position":3,"name":"Long Ideas","item":"https://seekingalpha.com/stock-ideas/long-ideas"},{"@type":"ListItem","position":4,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4907045-billiontoone-starting-2026-strong"},"author":{"@type":"Person","name":"The Value…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
